CSIRO Publishing blank image blank image blank image blank imageBooksblank image blank image blank image blank imageJournalsblank image blank image blank image blank imageAbout Usblank image blank image blank image blank imageShopping Cartblank image blank image blank image You are here: Journals > Sexual Health   
Sexual Health
Journal Banner
  Publishing on sexual health from the widest perspective
 
blank image Search
 
blank image blank image
blank image
 
  Advanced Search
   

Journal Home
About the Journal
Editorial Committee
Contacts
Content
Online Early
Current Issue
Just Accepted
All Issues
Special Issues
Sample Issue
Call for Papers
For Authors
General Information
Instructions to Authors
Submit Article
Open Access
For Referees
Referee Guidelines
Review Article
Annual Referee Index
For Advertisers
For Subscribers
Subscription Prices
Customer Service

blue arrow e-Alerts
blank image
Subscribe to our Email Alert or RSS feeds for the latest journal papers.

red arrow Connect with us
blank image
facebook twitter youtube

red arrow Interview with Kit Fairley
blank image
Hear Kit Fairley speak about what is sexual health.

red arrow Call for Papers
blank image
We are seeking contributions for a Special Issue.. More

 

Article << Previous     |     Next >>   Contents Vol 8(3)

Treatment for prevention of HIV transmission in a localised epidemic: the case for South Australia

Kelly-Jean Heymer A and David P. Wilson A B

A National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Darlinghurst, Sydney, NSW 2010, Australia.
B Corresponding author. Email: dwilson@nchecr.unsw.edu.au

Sexual Health 8(3) 280-294 http://dx.doi.org/10.1071/SH10084
Submitted: 8 July 2010  Accepted: 30 November 2010   Published: 23 May 2011


 
PDF (714 KB) $25
 Export Citation
 Print
  
Abstract

Background: Discussion is currently taking place among international HIV/AIDS groups around increasing HIV testing and initiating earlier use of antiretroviral therapy (ART) among people diagnosed with HIV as a method to reduce the spread of HIV. In this study, we explore the expected epidemiological impact of this strategy in a small population in which HIV transmission is predominantly confined to men who have sex with men (MSM). Methods: A deterministic mathematical transmission model was constructed to investigate the impacts of strategies that increase testing and treatment rates, and their likely potential to mitigate HIV epidemics among MSM. Our novel model distinguishes men in the population who are more easily accessible to prevention campaigns through engagement with the gay community from men who are not. This model is applied to the population of MSM in South Australia. Results: Our model-based findings suggest that increasing testing rates alone will have minimal impact on reducing the expected number of infections compared to current conditions. However, in combination with increases in treatment coverage, this strategy could lead to a 59–68% reduction in the number of HIV infections over the next 5 years. Targeting men who are socially engaged with the gay community would result in the majority of potential reductions in incidence, with only minor improvements possible by reaching all other MSM. Conclusions: Investing in strategies that will achieve higher coverage and earlier initiation of treatment to reduce infectiousness of HIV-infected individuals could be an effective strategy for reducing incidence in a population of MSM.

Additional keywords: HIV, mathematical model, men who have sex with men, test and treat, South Australia.


References

[1]  Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 2009; 373: 48–57.
CrossRef |

[2]  Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med 2000; 342: 921–9.
CrossRef |

[3]  Vernazza PL, Gilliam BL, Dyer J, Fiscus SA, Eron JJ, Frank AC, et al Quantification of HIV in semen: correlation with antiviral treatment and immune status. AIDS 1997; 11: 987–93.
CrossRef |

[4]  Vernazza PL, Troiani L, Flepp MJ, Cone RW, Schock J, Roth F, et al Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study. AIDS 2000; 14: 117–21.
CrossRef |

[5]  Zhang H, Dornadula G, Beumont M, Livornese L. Zhang H, Dornadula G, Beumont M, Livornese L. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N Engl J Med 1998; 339: 1803–9.
CrossRef |

[6]  Porco TC, Martin JN, Page-Shafer KA, Cheng A, Charlebois E, Grant RM, et al Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS 2004; 18: 81–8.
CrossRef |

[7]  Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, Cohen CR, et al Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 2010; 375: 2092–8.
CrossRef |

[8]  Attia S, Egger M, Müller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 2009; 23: 1397–404.
CrossRef |

[9]  Wilson DP. Universal voluntary HIV testing and immediate antiretroviral therapy. Lancet 2009; 373: 1077–8, author reply 1080–1.
CrossRef |

[10]  Dieffenbach CW, Fauci AS. Universal voluntary testing and treatment for prevention of HIV transmission. JAMA 2009; 301: 2380–2.
CrossRef |

[11]  Wagner BG, Kahn JS, Blower S. Should we try to eliminate HIV epidemics by using a ‘test and treat’ strategy? AIDS 2010; 24: 775–6.
CrossRef |

[12]  Wilson DP. Evidence is still required for treatment as prevention for riskier routes of HIV transmission. AIDS 2010; 24: 2891–2.
CrossRef |

[13]  Das M, Lee Chu P, Santos G-M, Scheer S, Vittinghoff E, McFarland W, et al Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One 2010; 5: e11068.
CrossRef |

[14]  van Griensven F, de Lind van Wijngaarden JW, Baral S, Grulich A. The global epidemic of HIV infection among men who have sex with men. Curr Opin HIV AIDS 2009; 4: 300–7.
CrossRef |

[15]  Grulich AE, Kaldor JM. Trends in HIV incidence in homosexual men in developed countries. Sex Health 2008; 5: 113–8.
CrossRef |

[16]  Sullivan PS, Hamouda O, Delpech V, Geduld JE, Prejean J, Semaille C, et al Reemergence of the HIV epidemic among men who have sex with men in North America, Western Europe, and Australia, 1996–2005. Ann Epidemiol 2009; 19: 423–31.
CrossRef |

[17]  Jin F, Jansson J, Law M, Prestage GP, Zablotska I, Imrie JCG, et al Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART. AIDS 2010; 24: 907–13.
CrossRef |

[18]  Lima VD, Hogg RS, Montaner JS. Expanding HAART treatment to all currently eligible individuals under the 2008 IAS-USA Guidelines in British Columbia, Canada. PLoS One 2010; 5: e10991.
CrossRef |

[19]  National Centre in HIV Epidemiology and Clinical Research. In: McDonald A, editor. HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia. Annual surveillance report. Sydney: National Centre in HIV Epidemiology and Clinical Research, University of New South Wales; 2009.

[20]  Wilson DP, Hoare A, Regan D, Wand H, Law M. Mathematical models to investigate recent trends in HIV notifications among men who have sex with men in Australia. Sydney: National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales; 2008.

[21]  Prestage G, Ferris J, Grierson J, Thorpe R, Zablotska I, Imrie J, et al Homosexual men in Australia: population, distribution and HIV prevalence. Sex Health 2008; 5: 97–102.
CrossRef |

[22]  Rawstorne P, Holt M, Kippax S, Worth H, Wilkinson J, Bittman M. E-Male survey 2008: key findings from a national online survey of men who have sex with men. Sydney: National Centre in HIV Social Research; 2009.

[23]  Frankland A, Zablotska I, Prestage G, O’Connor S, Martin P, Imrie J. Adelaide gay community periodic survey. Sydney: National Centre in HIV Social Research, University of New South Wales; 2007.

[24]  Kippax S, Connell R, Dowsett GW, Crawford J. Sustaining safe sex: gay communities respond to AIDS. London: Routledge; 1993.

[25]  Wilson DP, Hoare A, Regan DG, Law MG. Importance of promoting HIV testing for preventing secondary transmissions: modelling the Australian HIV epidemic among men who have sex with men. Sex Health 2009; 6: 19–33.
CrossRef |

[26]  Prestage G, Hudson J, Bradley J, Down I, Sutherland R, Corrigan N, et al. TOMS: three or more study. Sydney: National Centre in HIV Epidemiology and Clinical Research, University of New South Wales; 2008.

[27]  Lima VD, Johnston K, Hogg RS, Levy AR, Harrigan PR, Anema A, et al Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic. J Infect Dis 2008; 198: 59–67.
CrossRef |

[28]  Velasco-Hernandez JX, Gershengorn HB, Blower SM. Could widespread use of combination antiretroviral therapy eradicate HIV epidemics? Lancet Infect Dis 2002; 2: 487–93.
CrossRef |

[29]  Baggaley RF, Garnett GP, Ferguson NM. Modelling the impact of antiretroviral use in resource-poor settings. PLoS Med 2006; 3: e124.
CrossRef |

[30]  Salomon JA, Hogan DR. Evaluating the impact of antiretroviral therapy on HIV transmission. AIDS 2008; 22: S149–59.
CrossRef |

[31]  Johnston KM, Levy AR, Lima VD, Hogg RS, Tyndall MW, Gustafson P, et al Expanding access to HAART: a cost-effective approach for treating and preventing HIV. AIDS 2010; 24: 1929–35.
CrossRef |

[32]  Jin F, Crawford J, Prestage GP, Zablotska I, Imrie J, Kippax SC, et al Unprotected anal intercourse, risk reduction behaviours, and subsequent HIV infection in a cohort of homosexual men. AIDS 2009; 23: 243–52.
CrossRef |

[33]  Prestage G, McCann PD, Hurley M, Bradley J, Down I, Brown G. Pleasure and sexual health: The PASH Study, 2009. Sydney: National Centre in HIV Epidemiology and Clinical Research; 2010.

[34]  Kinloch-de Loës S, Hirschel BJ, Hoen B, Cooper DA, Tindall B, Carr A, et al A controlled trial of zidovudine in primary human immunodeficiency virus infection. N Engl J Med 1995; 333: 408–13.
CrossRef |

[35]  Hammer SM, Saag MS, Schechter M, Montaner JSG, Schooley RT, Jacobsen DM, et al Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society – USA panel. JAMA 2006; 296: 827–43.
CrossRef |

[36]  Rawstorne P, Holt M, Kippax S, Worth H, Wilkinson J, Bittman M. Supplemental data analysis to the E-Male survey: data comparisons of the E-Male survey in South Australia and the Adelaide Gay Community Periodic Survey. Sydney: NCHSR, University of New South Wales; 2009.

[37]  Davis KR, Weller SC. The effectiveness of condoms in reducing heterosexual transmission of HIV. Fam Plann Perspect 1999; 31: 272–9.
CrossRef |

[38]  Weller SC, Davis KR. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev 2002; : CD003255.
CrossRef |

[39]  Pinkerton SD, Abtramson PR. Effectiveness of condoms in preventing HIV transmission. Soc Sci Med 1997; 44: 1303–12.
CrossRef |

[40]  Weller SC. A meta-analysis of condom effectiveness in reducing sexually transmitted HIV. Soc Sci Med 1993; 36: 1635–44.
CrossRef |

[41]  Fitch TJ, Stine C, Hager WD, Mann J, Adam MB, McIlhaney J. Condom effectiveness: factors that influence risk reduction. Sex Transm Dis 2002; 29: 811–7.
CrossRef |

[42]  Van de Ven P, Mao L, Fogarty A, Rawstorne P, Crawford J, Prestage G, et al Undetectable viral load is associated with sexual risk taking in HIV serodiscordant gay couples in Sydney. AIDS 2005; 19: 179–84.
CrossRef |

[43]  National Centre in HIV Social Research. National Centre in HIV Social Research annual report of trends in behaviour. Sydney: NCHSR, University of New South Wales; 2006.

[44]  Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr 2005; 39: 446–53.
CrossRef |

[45]  Cleary PD, Van Devanter N, Rogers TF, Singer E, Shipton-Levy R, Steilen M, et al Behavior changes after notification of HIV infection. Am J Public Health 1991; 81: 1586–90.
CrossRef |

[46]  Colfax GN, Buchbinder SP, Cornelisse PGA, Vittinghoff E, Mayer K, Celum C. Sexual risk behaviors and implications for secondary HIV transmission during and after HIV seroconversion. AIDS 2002; 16: 1529–35.
CrossRef |

[47]  McCusker J, Stoddard AM, Mayer KH, Zapka J, Morrison C, Saltzman SP. Effects of HIV antibody test knowledge on subsequent sexual behaviors in a cohort of homosexually active men. Am J Public Health 1988; 78: 462–7.
CrossRef |

[48]  Saah AJ, Hoover DR, Weng S, Carrington M, Mellors J, Rinaldo CR. Saah AJ, Hoover DR, Weng S, Carrington M, Mellors J, Rinaldo CR. Association of HLA profiles with early plasma viral load, CD4+ cell count and rate of progression to AIDS following acute HIV-1 infection. Multicenter AIDS Cohort Study. AIDS 1998; 12: 2107–13.
CrossRef |

[49]  Smith DK, Valleroy LA, Warren DL, Vlahov D, Schuman P, Stein MD, et al Design and baseline participant characteristics of the Human Immunodeficiency Virus Epidemiology Research (HER) study: a prospective cohort study of human immunodeficiency virus infection in US women. Am J Epidemiol 1997; 146: 459–69.

[50]  Valleroy LA, MacKellar DA, Karon JM, Rosen DH, McFarland W, Shehan DA, et al HIV prevalence and associated risks in young men who have sex with men. Young Men’s Survey Study Group. JAMA 2000; 284: 198–204.
CrossRef |

[51]  Law MG, Prestage G, Grulich A, Van de Ven P, Kippax S. Modelling the effect of combination antiretroviral treatments on HIV incidence. AIDS 2001; 15: 1287–94.
CrossRef |

[52]  Mellors JW, Munoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, et al Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997; 126: 946–54.

[53]  Worm SW, Friis-Møller N, Sabin CA, Sjøl A, Lundgren JD, Salbøl-Brandt R, et al Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study. AIDS 2010; 24: 1537–48.

[54]  Ledergerber B, and The PLATO Collaboration. Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes. Lancet 2004; 364: 51–62.
CrossRef |

[55]  Jin F, Jansson J, Law M, Prestage GP, Zablotska I, Imrie JCG, et al Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART. AIDS 2010; 24: 907–13.
CrossRef |

[56]  Wilson DP, Law MG, Grulich AE, Cooper DA, Kaldor JM. Relation between HIV viral load and infectiousness: a model-based analysis. Lancet 2008; 372: 314–20.
CrossRef |

[57]  Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000; 342: 921–9.
CrossRef |

[58]  Australian HIV Observational Database Annual Report. Sydney: National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales; 2009.

[59]  Lodwick RK, Smith CJ, Youle M, Lampe FC, Tyrer M, Bhagani S, et al Stability of antiretroviral regimens in patients with viral suppression. AIDS 2008; 22: 1039–46.
CrossRef |


   
Subscriber Login
Username:
Password:  

 
    
Legal & Privacy | Contact Us | Help

CSIRO

© CSIRO 1996-2014